Navigation Links
Fragile X, Down Syndromes Linked to Faulty Brain Communication,,Stanford Researcher Finds

drome's name suggests, the responsible gene, called Fmr1, is located on the X chromosome. Because boys have only one X chromosome while girls have two, boys are usually more severely affected when Fmr1 is mutated. Girls are not immune to the condition, however. A phenomenon called X-inactivation, which randomly silences one member of every X chromosome pair, creates a mosaic of affected and unaffected nerve cells in the brain.

In some conditions linked to the X chromosome, such as hemophilia, the normal cells can cover for their useless peers. Not so for an elite corps of brain neurons. Here, where cooperation and communication are key, a few deadbeats in the mix can be disastrous.

The researchers' discovery of the muddled communication networks in the brain hinged on two advances. One was their creation of an Fmr1 mosaic mouse with brain characteristics similar to those of people with Fragile X. The other was the use of specialized microscopes and tiny needles to eavesdrop directly on individual conversations between two cells. Before this study, investigators relied on a strain of mice in which every cell carried a mutated Fmr1 gene, and they inferred how cells communicated by results from experiments on groups of cells.

The new approach allowed Madison's team to see that cells with a mutated Fmr1 gene have a very selective flaw: they are less likely than normal cells to reach out and form connections, or synapses, with their neighbors. Although normal cells in the mosaic brain can reroute around these potential dead ends, the resulting neural network has fewer cells and is less complex. "If, for example, 10 percent of normal nerve cells are now responsible for half your neural network, the information-carrying capacity of your brain goes down," he said.

Madison said the findings from this study point researchers in a new direction. "Until now the emphasis in the field has been on the receiving, or post-synaptic, side of the synapse," h
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Soliris Effective in PNH Patients With History of Aplastic Anemia and Myelodysplastic Syndromes
2. Study Continues to Show Patients With Myelodysplastic Syndromes Treated With Revlimid are Living Longer and Remaining Transfusion Independent
3. Algeta Demonstrates Targeted Cancer-killing Potential of Novel Alpha Particle Linked Antibodies in Leading Medical Journal Blood
4. Diabetes Linked to Higher Parkinsons Risk
5. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
6. Stanford Researchers Find Brain Pathway of Depression in Rats
7. Suven Life Sciences Presenting Pre-clinical data of their NCE’s SUVN-502 and SUVN-507at International Brain Research Organization (IBRO) 2007 World Congress of Neuroscience
8. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
9. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
10. Phase 2 Results for EntreMeds Panzem NCD Brain Cancer Study Presented at ASCO
11. Merck at ASCO 2007: Encouraging Results in Progression-Free Survival in Patients With Aggressive Brain Tumors (glioblastoma) Using Cilengitide in Phase I/IIa Study
Post Your Comments:
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
(Date:1/15/2014)... Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. (NYSE: ... applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act ... tender offer by its indirect wholly-owned subsidiary, Sapphire Subsidiary ... common stock of Solta Medical, Inc. (NASDAQ: ...
(Date:1/14/2014)... HeartWare International, Inc . (NASDAQ: HTWR ... support technologies that are revolutionizing the treatment of advanced ... the fourth quarter of 2013 will be approximately $53 ... million. "Our full-year revenue growth of 87% ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 2HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 3HeartWare International Announces Preliminary Fourth Quarter 2013 Revenues 4
... provides most accurate view inside human body ... meeting of the American Society for Reproductive Medicine got ... the presentation of endoscopic gynecologic surgery performed for the ... F. Palter, MD, an obstetrician, gynecologist, reproductive endocrinologist and ...
... The Roy and Patricia Disney Family Cancer Center will be the ... to own all the latest oncology products from Elekta ... CMS software. , Rex Hoffman, M.D. is Medical Director ... Roy and Patricia Disney Family Cancer Center will be located. He ...
Cached Medicine Technology:Long Island Doctor Shows First '4K' Ultra-High Definition Surgery 2Long Island Doctor Shows First '4K' Ultra-High Definition Surgery 3Elekta Provides Complete Planning, Treatment and Workflow Solution for Roy and Patricia Disney Family Cancer Center 2Elekta Provides Complete Planning, Treatment and Workflow Solution for Roy and Patricia Disney Family Cancer Center 3
(Date:4/17/2014)... Colic affects about one in five infants in the ... during the first several months after birth. Research into ... promise; however, the April 1, 2014 issue of the ... on a study, "Probiotics and Infant Colic," concluding that ... for infant colic did not reduce crying or ...
(Date:4/17/2014)... University School of Medicine (BUSM) have discovered that ... an experimental model. The findings, reported in the ... , may lead to more effective treatments for ... of the leading causes of illness and death ... impact by limiting the productivity of workers and ...
(Date:4/17/2014)... An international team led by researchers at UC Davis ... plays a key role in cell division, also boosts ... the first time the complex has been shown to ... B1/Cdk1 an excellent target to control cellular energy production, ... was published online today in the journal Developmental ...
(Date:4/17/2014)... An international research team led by Cesar A. Arias, ... Center at Houston (UTHealth) has identified a new superbug ... The report appeared in the April 17 issue of ... The new superbug is part of a class of ... or MRSA, which is a major cause of hospital ...
(Date:4/17/2014)... days to find a colored ribbon representing a disease. A ... what color ribbon does one think of with lung cancer?, ... many suffering from the disease, black may be the only ... of lung cancer patients, primarily smokers between the ages of ... the stigma often felt by these patients, the emotional toll ...
Breaking Medicine News(10 mins):Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Dual role: Key cell division proteins also power up mitochondria 2Health News:New MRSA superbug emerges in Brazil 2Health News:Unraveling the 'black ribbon' around lung cancer 2
... expert says, , WEDNESDAY, July 22 (HealthDay News) -- When ... kind of snack that matters, but who eats it. , ... women, the healthy-weight women wanted less of the treat over ... non-obese women respond to high-energy, high-density snacks in different ways," ...
... , , IRVINE, Calif., July ... Pulse CO-Oximetry and Measure-Through Motion and Low-Perfusion pulse oximetry, today announced it ... 4, 2009 after the market closes on Tuesday, August 4, 2009. , ... results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will ...
... , , , ... July 22 Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. ... cooperative group-sponsored randomized Phase 2 trial in advanced metastatic breast ... evaluated Nexavar(R) (sorafenib) tablets in combination with the oral chemotherapeutic, ...
... , , BATON ROUGE, ... manage cleanup efforts in hurricane-ravaged areas. Assisting in the diagnosis and ... which one is practically required to live at the gym and work ... careers are both varied and interesting. . .many of them coming with ...
... ... HSA Bank, two innovators in health savings accounts, have announced a new marketing ... easy access to HSA Bank through the My HSA Rewards website to learn ... HSA Bank customers will be given the opportunity to enroll in My HSA ...
... The Centers ... much as 4.5 percent by the year 2010. The additional costs could be passed along ... ... likely increase costs to seniors for their Medicare Advantage health insurance plans, in April the ...
Cached Medicine News:Health News:Eating Habits in the Obese May Echo Drug Addicts' Patterns 2Health News:Eating Habits in the Obese May Echo Drug Addicts' Patterns 3Health News:Masimo to Report Second Quarter 2009 Financial Results on August 4, 2009 2Health News:Masimo to Report Second Quarter 2009 Financial Results on August 4, 2009 3Health News:Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer 2Health News:Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer 3Health News:Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer 4Health News:Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer 5Health News:Nexavar in Combination with Chemotherapy Shown to Extend Progression-Free Survival in Patients with Advanced Breast Cancer 6Health News:MedVance Institute To Offer New High-Demand Courses 2Health News:MedVance Institute To Offer New High-Demand Courses 3Health News:HSA Bank and My HSA Rewards Offer a New Way for HSA Bank Customers to Help Pay for Their Health Care 2Health News:HSA Bank and My HSA Rewards Offer a New Way for HSA Bank Customers to Help Pay for Their Health Care 3Health News:Medicare Agency Announces Decreased Payments to Medicare Advantage Insurers in 2010, Says MedicareSupplementPlans.com 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: